ZA965750B - Farnesyl transferase inhibitors their preparation and pharmaceutical composition comprising them - Google Patents
Farnesyl transferase inhibitors their preparation and pharmaceutical composition comprising themInfo
- Publication number
- ZA965750B ZA965750B ZA965750A ZA965750A ZA965750B ZA 965750 B ZA965750 B ZA 965750B ZA 965750 A ZA965750 A ZA 965750A ZA 965750 A ZA965750 A ZA 965750A ZA 965750 B ZA965750 B ZA 965750B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical composition
- transferase inhibitors
- farnesyl transferase
- farnesyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9508423A FR2736638B1 (fr) | 1995-07-12 | 1995-07-12 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA965750B true ZA965750B (en) | 1997-01-27 |
Family
ID=9480919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA965750A ZA965750B (en) | 1995-07-12 | 1996-07-05 | Farnesyl transferase inhibitors their preparation and pharmaceutical composition comprising them |
Country Status (8)
Country | Link |
---|---|
US (1) | US5889053A (de) |
EP (1) | EP0842150A1 (de) |
JP (1) | JPH11508911A (de) |
AU (1) | AU6523396A (de) |
CA (1) | CA2224411A1 (de) |
FR (1) | FR2736638B1 (de) |
WO (1) | WO1997003047A1 (de) |
ZA (1) | ZA965750B (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2780974B1 (fr) * | 1998-07-08 | 2001-09-28 | Sod Conseils Rech Applic | Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique |
ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US8173629B2 (en) | 2006-09-22 | 2012-05-08 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
RS58936B1 (sr) | 2007-01-10 | 2019-08-30 | Msd Italia Srl | Indazoli supstituisani amidom kao inhibitori poli(adp-riboza)polimeraze (parp) |
CA2679659C (en) | 2007-03-01 | 2016-01-19 | Novartis Ag | Pim kinase inhibitors and methods of their use |
EP2152700B1 (de) | 2007-05-21 | 2013-12-11 | Novartis AG | Csf-1r-hemmer, zusammensetzungen und anwendungsverfahren |
US8389553B2 (en) | 2007-06-27 | 2013-03-05 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
US7932036B1 (en) | 2008-03-12 | 2011-04-26 | Veridex, Llc | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
CN102480966B (zh) | 2009-06-12 | 2015-09-16 | 达娜-法勃肿瘤研究所公司 | 融合的杂环化合物及其用途 |
CN104945382B (zh) | 2009-10-14 | 2020-02-07 | 默沙东公司 | 提高p53活性的取代的哌啶和其用途 |
EP2519517B1 (de) | 2009-12-29 | 2015-03-25 | Dana-Farber Cancer Institute, Inc. | Typ-ii-raf-kinase-hemmer |
KR20130006664A (ko) | 2010-03-16 | 2013-01-17 | 다나-파버 캔서 인스티튜트 인크. | 인다졸 화합물 및 그의 용도 |
WO2011163330A1 (en) | 2010-06-24 | 2011-12-29 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
CA3186328A1 (en) | 2010-07-28 | 2012-02-02 | Janssen Pharmaceutica Nv | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors |
WO2012018754A2 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US9029341B2 (en) | 2010-08-17 | 2015-05-12 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
EP2608669B1 (de) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer |
EP2613782B1 (de) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazolderivate als erk-hemmer |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
US9260471B2 (en) | 2010-10-29 | 2016-02-16 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) |
WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
US20140045847A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
EP2770987B1 (de) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Neue verbindungen als erk-hemmer |
US9382239B2 (en) | 2011-11-17 | 2016-07-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-terminal kinase (JNK) |
EP3453762B1 (de) | 2012-05-02 | 2021-04-21 | Sirna Therapeutics, Inc. | Sina-zusammensetzungen |
MX2015004041A (es) | 2012-09-28 | 2015-07-06 | Merck Sharp & Dohme | Compuestos novedosos que son inhibidores de erk. |
EP2909194A1 (de) | 2012-10-18 | 2015-08-26 | Dana-Farber Cancer Institute, Inc. | Hemmer der cyclinabhängigen kinase 7 (cdk7) |
US9758522B2 (en) | 2012-10-19 | 2017-09-12 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
WO2014085216A1 (en) | 2012-11-28 | 2014-06-05 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
EP2951180B1 (de) | 2013-01-30 | 2018-05-02 | Merck Sharp & Dohme Corp. | 2,6,7,8-substituierte purine als hdm2-inhibitoren |
EP3041938A1 (de) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Kreisförmige polynukleotide |
AU2014337122B2 (en) | 2013-10-18 | 2019-01-03 | Dana-Farber Cancer Institute, Inc. | Heteroaromatic compounds useful for the treatment of proliferative diseases |
EP3057956B1 (de) | 2013-10-18 | 2021-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclische inhibitoren der cyclin-dependent-kinase 7 (cdk7) |
US10017477B2 (en) | 2014-04-23 | 2018-07-10 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
JP6861166B2 (ja) | 2015-03-27 | 2021-04-21 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | サイクリン依存性キナーゼの阻害剤 |
AU2016276963C1 (en) | 2015-06-12 | 2021-08-05 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
HRP20211976T1 (hr) | 2015-08-17 | 2022-03-18 | Kura Oncology, Inc. | Postupci liječenja bolesnika od raka inhibitorima farnezil transferaze |
WO2017044858A2 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
EP3534885B1 (de) | 2016-11-03 | 2021-01-20 | Kura Oncology, Inc. | Farnesyltransferase-inhibitoren zur verwendung bei der behandlung von krebs |
US10851164B2 (en) | 2017-04-13 | 2020-12-01 | Aduro Biotech Holdings, Europe B.V. | Anti-SIRPα antibodies |
WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
WO2019113269A1 (en) | 2017-12-08 | 2019-06-13 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
EP3833668A4 (de) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | Prmt5-inhibitoren |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
WO2020190604A1 (en) | 2019-03-15 | 2020-09-24 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2044333A1 (en) * | 1990-06-12 | 1991-12-13 | Jackson B. Gibbs | Chemotherapeutic agents |
US5504212A (en) * | 1992-10-29 | 1996-04-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5705686A (en) * | 1993-05-18 | 1998-01-06 | University Of Pittsburgh | Inhibition of farnesyl transferase |
-
1995
- 1995-07-12 FR FR9508423A patent/FR2736638B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-05 ZA ZA965750A patent/ZA965750B/xx unknown
- 1996-07-10 JP JP9505563A patent/JPH11508911A/ja active Pending
- 1996-07-10 CA CA002224411A patent/CA2224411A1/fr not_active Abandoned
- 1996-07-10 WO PCT/FR1996/001071 patent/WO1997003047A1/fr not_active Application Discontinuation
- 1996-07-10 EP EP96924961A patent/EP0842150A1/de not_active Ceased
- 1996-07-10 AU AU65233/96A patent/AU6523396A/en not_active Abandoned
-
1998
- 1998-01-09 US US09/005,154 patent/US5889053A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0842150A1 (de) | 1998-05-20 |
JPH11508911A (ja) | 1999-08-03 |
AU6523396A (en) | 1997-02-10 |
CA2224411A1 (fr) | 1997-01-30 |
WO1997003047A1 (fr) | 1997-01-30 |
US5889053A (en) | 1999-03-30 |
FR2736638A1 (fr) | 1997-01-17 |
FR2736638B1 (fr) | 1997-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965750B (en) | Farnesyl transferase inhibitors their preparation and pharmaceutical composition comprising them | |
ZA965868B (en) | Farnesyl transferase inhibitors their preparation and pharmaceutical compositions comprising them | |
ZA961072B (en) | New farnesyl transferase inhibitors their preparation and the pharmaceutical compositions which contain them | |
ZA961073B (en) | New farnesyl transferase inhibitors their preparation and the pharmaceutical compositions which contain them | |
NZ305254A (en) | Farnesyl protein inhibitors and pharmaceutical compositions thereof | |
ZA96258B (en) | New farnesyl tranferase inhibitors their preparation and the pharmaceutical compositions which contain them | |
HUP9900185A3 (en) | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives, their preparation, pharmaceutical compositions containing them and their use | |
IL133470A0 (en) | Inhibitors of farnesyl protein transferase and pharmaceutical compositions containing same | |
IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
IL119466A0 (en) | Thrombin inhibitors their preparation and pharmaceutical compositions containing them | |
IL107587A0 (en) | Farnesyl derivatives and pharmaceutical compositions containing them | |
IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
IL114925A0 (en) | Glycinamide derivatives their preparation and pharmaceutical compositions containing them | |
IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
HUP0203054A3 (en) | Farnesyl protein transferase inhibitors, pharmaceutical compositions containing them and their use | |
ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
HUP9602196A3 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
IL117397A (en) | Substituted naphthyl compounds and pharmaceutical compositions comprising them | |
IL116825A0 (en) | Vitamin d derivatives their preparation and pharmaceutical compositions containing them | |
IL118672A0 (en) | Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them | |
IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them | |
ZA954652B (en) | New farnesyl transferase inhibitors their preparation and the pharmaceutical compositions which contain them | |
HU9500386D0 (en) | Benzodiazepine derivatives and pharmaceutical compositions containing them |